New Elite Feature: Chart Templates — Your indicators and design everywhere on Finviz

mdxhealth

Contributing Author

Recent Articles by mdxhealth

Mar-16	Mdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 MDXH +5.31% GlobeNewswire
Feb-26	Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results MDXH GlobeNewswire
Feb-12	Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 MDXH GlobeNewswire
Jan-12	MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences MDXH +5.21% GlobeNewswire
Jan-06	Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer MDXH GlobeNewswire
Nov-12	Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 MDXH -7.42% GlobeNewswire
Nov-03	Mdxhealth to Release Third Quarter 2025 Financial Results on November 12 MDXH GlobeNewswire
Sep-15	Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne MDXH GlobeNewswire
Aug-05	Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne MDXH +10.44% MDXH GlobeNewswire
Jul-03	Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change MDXH GlobeNewswire
May-14	MDxHealth Reports Q1-2025 Results MDXH +6.74% MDXH GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)